These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3221938)

  • 21. Synthesis of some Mannich bases with dimethylamine and their hydrazones and evaluation of their cytotoxicity against Jurkat cells.
    Kucukoglu K; Gul M; Atalay M; Mete E; Kazaz C; Hanninen O; Gul HI
    Arzneimittelforschung; 2011; 61(6):366-71. PubMed ID: 21827048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of nuclear-substituted styryl ketones and related compounds for antitumor and cytotoxic properties.
    Dimmock JR; Taylor WG
    J Pharm Sci; 1975 Feb; 64(2):41-9. PubMed ID: 1127603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxicity of Mannich bases of alpha-arylidene-beta-ketoesters and related compounds against EMT6 mammary carcinoma cells.
    Dimmock JR; Erciyas E; Bigam GE; Kirkpatrick DL; Duke MM
    Drug Des Deliv; 1990 Dec; 7(1):51-8. PubMed ID: 2096834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of some Mannich bases of conjugated styryl ketones against Candida albicans.
    Dimmock JR; Kumar P; Manavathu EK; Obedeanu N; Grewal J
    Pharmazie; 1994 Dec; 49(12):909-12. PubMed ID: 7838880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and study of the anti-leukaemic activity of N,N'-substituted amidines and bis-amidines.
    Dumont P; Fuks R; Atassi G; Hanocq M
    J Pharm Belg; 1985; 40(6):373-86. PubMed ID: 3831292
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and anticancer activity of new phenyl-ring substituted 4-morpholino-1-phenylthio-2-butanones [Mannich bases].
    Siatra-Papastaikoudi T; Tsotinis A; Chinou I; Roussakis C
    Farmaco; 1994 Mar; 49(3):221-3. PubMed ID: 8043174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,2,3,4,-Tetrahydro-1,2-diazepine derivatives: synthesis and evaluation of antileukemic activity.
    Dal Piaz V; Ciciani G
    Farmaco Sci; 1988 Nov; 43(11):943-9. PubMed ID: 3251787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chelating agents as potential antitumorals: alpha-(N)-heterocyclic hydrazones and bis-alpha-(N)-heterocyclic hydrazones.
    Savini L; Massarelli P; Chiasserini L; Nencini C; Pellerano C
    Farmaco; 1997 Oct; 52(10):609-13. PubMed ID: 9507672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-antileukemic activity relationship study of B- and D-ring modified and nonmodified steroidal esters of 4-methyl-3-N,N-bis(2-chloroethyl)amino benzoic acid: a comparative study.
    Fousteris MA; Koutsourea AI; Arsenou ES; Papageorgiou A; Mourelatos D; Nikolaropoulos SS
    Anticancer Drugs; 2007 Oct; 18(9):997-1004. PubMed ID: 17704649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
    Lin TS; Fischer PH; Marsh JC; Prusoff WH
    Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E; Menconi E; Barzi AM
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-(2-Oxo-3-indolinylidene)thiazolidine-2,4-dione-1,3-di-Mannich base derivatives: synthesis and evaluation for antileukemic activity.
    Eshba NH; Salama HM
    Pharmazie; 1985 May; 40(5):320-2. PubMed ID: 4034634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural analogues of isatin and their antimicrobial activity.
    Maysinger D; Movrin M; Sarić MM
    Pharmazie; 1980 Jan; 35(1):14-6. PubMed ID: 7384170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity comparison of mitomycin C and mitomycin A analogues (review).
    Bradner WT; Remers WA; Vyas DM
    Anticancer Res; 1989; 9(4):1095-9. PubMed ID: 2510580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI; Plunkett W
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of antimicrobial activities of several mannich bases and their derivatives.
    Gul HI; Sahin F; Gul M; Ozturk S; Yerdelen KO
    Arch Pharm (Weinheim); 2005 Jul; 338(7):335-8. PubMed ID: 15981301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
    Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.
    Trafalis DT; Tsavdaridis D; Camoutsis C; Karayiani V; Mourelatos D; Dalezis P; Athanassiou A; Pangalis GA; Papageorgiou A
    Br J Haematol; 2005 Feb; 128(3):343-50. PubMed ID: 15667536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of anthracycline-resistant strains of P388 leukemia].
    Goncharova SA; Demidova NS; Shiriaeva OA; Shevtsova VN; Konovalova NP
    Eksp Onkol; 1987; 9(4):42-7. PubMed ID: 3678124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.